Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Personalized Medicine to Transform Modern Healthcare and Cross USD 1 Trillion by 2034 | DelveInsight

globenewswire.com
GEHC GE HealthCare is listed as a key AI in precision medicine company, suggesting its participation in a technologically driven and expanding healthcare market. ILMN Illumina is listed as a key company in the Next-Generation Sequencing market, highlighting its importance in a rapidly advancing field of genetic analysis. TMO Thermo Fisher Scientific is mentioned as a key company in the Next-Generation Sequencing market, indicating its role in a critical and growing area of scientific research and diagnostics. PACB Pacific Biosciences is named as a key company in the Next-Generation Sequencing market, highlighting its role in a crucial and expanding field of genetic analysis. AMWL American Well is mentioned as a key telehealth and telemedicine company, suggesting its role in the expanding market for virtual healthcare services. IBM IBM Corporation is mentioned as a key telehealth company, indicating its participation in the expanding digital health and remote care market. MD Medtronic is listed as a key telehealth company, suggesting its role in the growing market for technology-driven healthcare solutions. HON Honeywell International Inc. is listed as a key telehealth company, suggesting its participation in the growing market for connected health solutions. AAPL Apple Inc. is mentioned as a key digital health company, indicating its involvement in the expanding market for consumer health technology and services. MCK MCKESSON CORPORATION is listed as a key digital health company, suggesting its role in the distribution and technology aspects of the healthcare market.

Global Personalized Medicine to Transform Modern Healthcare and Cross USD 1 Trillion by 2034 | DelveInsight New York, USA, May 11, 2026 (GLOBE NEWSWIRE) -- Global Personalized Medicine to Transform Modern Healthcare and Cross USD 1 Trillion by 2034 | DelveInsight

The personalized medicine market is experiencing strong growth driven by advances in genomics, biomarker-based diagnostics, and targeted therapies. The increasing prevalence of chronic diseases and cancer is accelerating demand for tailored treatment approaches that improve efficacy and reduce adverse effects. Technological innovations such as next-generation sequencing and AI-powered data analytics are further enabling precise patient stratification.

DelveInsight’s Personalized Medicine Market Insights report provides the current and forecast market analysis, individual leading personalized medicine companies’ market shares, challenges, personalized medicine market drivers, barriers, trends, and key personalized medicine companies in the market.

Personalized Medicine Market Summary

To read more about the latest highlights related to the personalized medicine market, get a snapshot of the key highlights @ https://www.delveinsight.com/sample-request/personalized-medicine-market

Key Factors Contributing to the Rise in Growth of the Personalized Medicine Market

Get a sneak peek at the personalized medicine market dynamics @ Personalized Medicine Market Trends

Regional Personalized Medicine Market Insights

North America

Europe

Asia-Pacific

To know more about why North America is leading the market growth in the personalized medicine market, get a snapshot of the Personalized Medicine Market Share

Recent Developmental Activities in the Personalized Medicine Market

What is Personalized Medicine?

Personalized medicine, also known as precision medicine, is an approach to healthcare that tailors medical treatment and preventive strategies to an individual’s unique biological profile, lifestyle, and environment. It leverages advanced technologies such as genomics, biomarker analysis, and data analytics to understand how a person’s genetic makeup influences disease risk and response to therapies. Unlike the traditional “one-size-fits-all” model, personalized medicine enables clinicians to select the most effective treatments with fewer side effects, improving patient outcomes. This approach is particularly transformative in areas like oncology, rare diseases, and chronic conditions, where targeted therapies can significantly enhance treatment efficacy and quality of life.

Personalized Medicine Market Assessment

Which MedTech key players in the personalized medicine market are set to emerge as the trendsetter explore @ Personalized Medicine Market Analysis

Table of Contents

Interested in knowing the personalized medicine market share by 2034? Click to get a snapshot of the Personalized Medicine Market Size

Related Reports

Artificial Intelligence in Precision Medicine Market

Artificial Intelligence in Precision Medicine Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key AI in precision medicine companies, including TEMPUS, GE HealthCare, Qure.ai, Envisionit Deep AI (Pty) Ltd., Avicenna.AI, Aignostics, Inc., Proscia Inc., Ultivue, Inc., Prenosis, Inc., IBEX, Cleerly, Inc., Paige AI, Inc., Densitas® Inc., Photocure ASA, iCAD, Inc., Eko Health, Inc., Owkin, Inc, Massive Bio, Deep Bio Inc., Atomwise Inc., and others.

Next-Generation Sequencing Market

Next-Generation Sequencing Market Insights, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key NGS companies, including Agilent Technologies, Inc., Illumina Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, QIAGEN, Thermo Fisher Scientific, PerkinElmer Inc., MedGenome, BGI, Pacific Biosciences, GENEWIZ, Oxford Nanopore Technologies plc., Psomagen, Inc., 10x Genomics, Takara Bio Inc., Zymo Research Corporation, NuGEN Technologies, Inc. (Tecan Trading AG), Vela Diagnostics, CD Genomics, HTG Molecular Diagnostics, Inc., and others.

Telehealth Market

Telehealth Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key telehealth companies, including Teladoc Health, Inc., Siemens, Cisco Systems, Inc., Koninklijke Philips N.V., IBM Corporation, Medtronic, Cerner Corporation, American Well, AMD Global Telemedicine, Joerns Healthcare., GlobalMed, OncoHealth, Allscripts Healthcare, LLC, Derma2go, SOCTelemed, Inc., Honeywell International Inc., Plantronics, Inc., Carium., Emmaus Life Sciences, Inc., Practo, and others.

Telemedicine Market

Telemedicine Market Insights, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key telemedicine companies, including Teladoc Health, Inc., MEDICI, American Well, Doximity, Inc., Practo, DocOnline, MeMD®, iCliniq, HealthTap, Inc., WELL Health Technologies Corp., Vesta Teleradiology, USARAD.CO, Samsung Health U.S, Rudolf Riester GmbH, SHL Telemedicine, Array Behavioral Care, SOC Telemed, Heidelberg Medical Consultancy & Health Tourism Pvt. Ltd., First Derm, DirectDerm, and others.

Digital Health Market

Digital Health Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key digital health companies, including Siemens Healthcare Private Limited, Cisco Systems, Inc., Oracle Cerner, Altera Digital Health Inc., Telefonica, Epic, AT&T, AmerisourceBergen, Candela Corporation., GE Healthcare, Samsung Health, MCKESSON CORPORATION, AliveCor, Inc., Acurable, Amwell, OMRON Healthcare, Inc., Apple Inc., SoftServe, AirStrip Technologies, Inc, Epic Systems Corporation, and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.